Background: Diffusion-weighted magnetic resonance imaging (DWI) is reported to be useful for detecting malignant lesions. The purpose of this study is to clarify characteristics of imaging, detection rate and sensitivity of DWI for recurrence or metastasis of lung cancer. Methods: A total of 36 lung cancer patients with recurrence or metastasis were enrolled in this study. While 16 patients underwent magnetic resonance imaging (MRI), computed tomography (CT) and positron emission tomography-computed tomography (PET-CT), 17 underwent MRI and CT, and 3 underwent MRI and PET-CT. Results: Each recurrence or metastasis showed decreased diffusion, which was easily recognized in DWI. The detection rate for recurrence or metastasis was 100% (36/36) in DWI, 89% (17/19) in PET-CT and 82% (27/33) in CT. Detection rate of DWI was significantly higher than that of CT (p=0.0244) but not significantly higher than that of PET-CT (p=0.22). When the optimal cutoff value of the apparent diffusion coefficient value was set as 1.70×10 -3 mm 2 /sec, the sensitivity of DWI for diagnosing recurrence or metastasis of lung cancer was 95.6%. Conclusions: DWI is useful for detection of recurrence and metastasis of lung cancer.
Introduction
Diffusion-weighted magnetic resonance imaging (DWI) exploits the random, translational motion, or so-called Brownian movement, of water molecules in biologic tissue (Le Bihan et al., 1988) . Recently, DWI has been used to detect the restricted diffusion of water molecules in the body. The primary use of DWI has been in brain imaging, mainly for the evaluation of intracranial tumors, acute ischemic stroke and demyelinating diseases (Tien et al., 1994; Sorensen et al., 1996) . Diffusion of water molecules in malignant tumors is generally restricted compared to that in normal tissue, resulting in a decreased apparent diffusion coefficient (ADC) value (Szafer et al., 1995; Takahara et al., 2004) .
MRI examination carries no risk of exposure to radiation, and the examination can be done in every hospital whereas hospitals equipped with PET-CT are limited because of the potential risk in handling the radioisotope of 18 F-FDG. Furthermore, MRI examination is relatively more affordable compared to a PET-CT examination. In terms of patient well-being patients do not have to fast before the DWI examination, do not need exogenous contrast medium, and less time is required for the examination. However, it is unclear whether DWI is useful for detection of recurrence or metastasis of lung cancer and what the characteristics of recurrence or metastasis of lung cancer are in DWI. The purpose of this study is to clarify the characteristics, detection rate and sensitivity of DWI of recurrence and metastasis of lung cancer.
Materials and Methods

Eligibility
The study protocol for examining DWI in patients with lung cancer was approved by the ethical committee of Kanazawa Medical University (the approval number: No.189). Informed consent to a general clinical practice for MRI was obtained from each patient after discussing the risks and benefits of the examinations. MRI, CT and/or PET-CT were performed within 2 weeks in each patient.
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The clinical prospective study started in May 2009. Patients who underwent surgery for lung cancer and whose later recurrence sites were diagnosed histopathologically through bronchoscopy, percutaneous biopsy, or sputum cytology, or were diagnosed radiographically were enrolled in this study. 
Magnetic resonance imaging (MRI)
All MRIs were obtained with a 1.5 T superconducting magnetic scanner (Magnetom Avanto; Siemens, Erlangen, Germany) with two anterior six-channel body phasedarray coils and two posterior spinal clusters (six-channels each). The conventional MRIs consisted of a coronal T1-weighted spin-echo sequence and coronal and axial T2-weighted fast spin-echo sequences. Diffusion-weighted magnetic resonance imagings (DWIs) using a single-shot echo-planar technique were performed under SPAIR (spectral attenuated inversion recovery) with respiratory triggered scan with the following parameter: TR/TE/flip angle, 3000-4500/65/90; diffusion gradient encoding in three orthogonal directions; b value = 0 and 800 s/mm 2 ; field of view, 350 mm; matrix size, 128x128. After image reconstruction, a 2-dimensional (2D) round or elliptical region of interest (ROI) was drawn on the lesion which was detected visually on the ADC map with reference to the T2-weghted image or CT by the radiologist (H.T.) with 39 years of MRI experience who was unaware of the patients' clinical data. Areas with necrosis were excluded from the ADC measurement. The procedure was repeated three times and the minimum ADC value was obtained. The radiologist (H.T.) and one pulmonologist (K.U.) with 30 years of experience evaluated the MRI data. A consensus was reached if there were any differences of opinion. The optimal cutoff value (OCV) for diagnosing malignancy in DWI was determined to be 1.70×10 -3 mm 2 /sec using receiver operating characteristics curve as reported in the previous article (Usuda et al., 2013) . Recurrence or metastasis from lung cancers with an ADC value of the same or less than the OCV was defined as positive. Recurrence or metastasis from lung cancers with an ADC value of more than the OCV or those that could not be detected on DWI was defined as negative.
Positron emission tomography -computed tomography (PET-CT)
PET-CT scanning was performed with a dedicated PET camera (SIEMENS Biograph Sensation 16, Erlangen Germany) before surgery. All patients fasted for 6 hours before scanning. The dose of 18-fluoro-2-deoxy-glucose ( 18 F-FDG) administered was 3.7MBq/Kg of body weight. After a 60-min uptake period, an emission scan was acquired for 3 min per bed position and a whole-body scan was performed on each patient using several bed positions according to the height of each patient. After image reconstruction, a 2-dimensional (2D) round region of interest (ROI) was drawn on a slice after visual detection of the highest count on the fused CT image by the radiologist (M.T.) with 14 years of radioisotope scintigraphy and PET-CT experience who was unaware of the patients' clinical data. The maximum standardized uptake value (SUVmax) was calculated as the 18 F-FDG accumulation within lesions.
Computed tomography (CT)
CT examinations were performed by using a multidetector row CT scanner, SOMATOM Definition Flash (SIEMENS, Forchheim, Germany). The instrument parameters at multidetector CT: Lung (120 KV, 160 mA, 16x0.75-mm collimation, and 5-mm section thickness reconstruction, window level of -500 Hounsfield unit (HU), window width of 1500 HU), mediastinum (160 mA, window level of 30 HU, window width of 400 HU), brain (300 mA, window level of 37 HU, window width of 90 HU) and abdomen (240 mA, window level of 30 HU, window width of 280 HU).
Detection rate of recurrence or metastasis of lung cancer by examination
For detection rate of recurrence or metastasis by examination, it was determined whether examinations were helpful or unhelpful in each case through discussion among doctors.
Statistical analysis
Statistical analysis was performed using StatView for Windows (Version 5.0; SAS Institute Inc. Cary, NC, USA). The data is expressed as the mean ± standard deviation. Differences of ratios between two groups were compared by using the χ2 test. A P value of <0.05 was considered statistically significant.
Results
Sixteen patients underwent MRI, CT and PET-CT, 17 underwent MRI and CT, and 3 underwent MRI and PET-CT. In the 36 lung cancer patients, recurrent or metastatic lesions of 12 patients were confirmed with pathological diagnosis. In the 24 patients whose recurrent or metastatic lesions were diagnosed radiographically, 7 patients died of lung cancer and 17 were alive with recurrence or metastasis as of June 2014.
Of the 36 lung cancer patients with recurrence or metastasis, recurrent or metastatic sites were: lung in 21, lymph nodes in 10, pleural cavity in 4, bone in 4, liver in 4, brain in 1 and spleen in 1 (Total number of evaluated sites: 45) ( Table 1) .
Pulmonary metastasis was detected in the right lung (Figure 1 ). It was recognized by CT, PET-CT and DWI. Pulmonary metastasis was presented as decreased diffusion in DWI. Usually in DWI, heart, blood vessels, bronchus and benign lesions would not show decreased diffusion, and would not likely be detected. Pulmonary metastasis was recognized by decreased diffusion in DWI (Figure 2) . Local recurrence in a residual lung was (Figure 4 ). In the CT, it was rather difficult for doctors to recognize the metastatic hilar and mediastinal lymph nodes. Pleural metastasis and nodal involvement were recognized clearly in DWI ( Figure  5 ). Non-malignant organs disappear in DWI. Although it was sometimes difficult to detect liver metastasis by unenhanced CT or PET-CT, it was easy to detect liver metastases by DWI because they were represented by Figure  7 . Bone scintigraphy showed multiple bone metastases.
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DWI showed not only multiple bone metastases but also multiple liver metastases. In the 16 patients who underwent DWI, CT and PET-CT, metastatic lesions were recognized by all these methods in 12 patients, recognized by DWI and PET-CT but not by CT in 2 patients, and recognized by DWI and CT but not by PET-CT in 2 other patients (Table 2 ). In the 17 patients who underwent DWI and CT, metastatic lesions were recognized by both methods in 13 patients and recognized by DWI but not by CT in 4 patients. In the 3 patients who underwent DWI and PET-CT, all metastatic lesions were recognized by DWI and PET-CT. On the whole, detection rate of recurrence or metastasis was 100% (36/36) in DWI, 89% (17/19) in PET-CT and 82% (27/33) in CT. Detection rate of DWI was significantly higher than that of CT (p=0.0244) but not significantly higher than that of . ADC values of recurrent or metastatic lesions were 1.31±0.278 in lung, 1.36±0.171 in lymph nodes, 1.10±0.149 in pleura, 1.06±0.267 in bone, 1.11±0.238 in liver, 0.989 in brain and 1.55 in spleen (Table 1) . Increased DWI signals showed every recurrent or metastatic lesion, and could be distinguished from noncancer sites. If the optimal cutoff value (OCV) of DWI for diagnosing malignancy was set to be 1.70×10 -3 mm 2 /sec, the sensitivity of DWI was 95.6% (43/45). Two metastatic lesions represented higher ADC value over the OCV.
In this series, ADC values of 19 primary lung cancers were obtained from previous MRI records. Comparison between ADC of primary lung cancer and ADC of metastatic lesions are represented in Figure 8 . The correlation coefficient of the ADCs was 0.0063, which meant less correlation between ADC of primary lung cancer and ADC of metastatic lesions.
Discussion
Detection of recurrence or metastasis of lung cancer is an important issue in the follow-up of the cancer treatment. Pulmonary metastases are easy to detect because they are recognized as new lesions. However, they are sometimes rather difficult to distinguish from benign lesions. PET-CT is used in the evaluation of these new lesions. Recently we have reported that DWI is superior to PET in the detection of primary lesions and nodal assessment of non-small cell lung cancers (Usuda et al., 2011) . The sensitivity of DWI was significantly higher than that of FDG-PET, and the accuracy of DWI was higher than that of FDG-PET in pulmonary nodules and mass lesions (Usuda et al., 2014) . The diagnostic efficacy of DWI is superior to that of PET-CT, and DWI can be used in assessment of malignancy in pulmonary nodules and mass lesions instead of PET-CT. Similarly, DWI can be used to distinguish benign from malignant lesions in the lung (Mori et al., 2008; Ohba et al., 2009) , in the thorax (Tondo et al., 2011) , in the prostate (Yamamura et al., 2011) , in the breast (Fornasa et al., 2011) and in the liver (Koike et al., 2009) . DWI was reported to be an effective alternative in future diagnosis and follow-up of bladder tumors because of its higher sensitivity, specificity and accuracy (Ceylan K et al., 2010) . Preoperative prediction of neurovascular bundle involvement of localized prostate cancer was reported to be possible by combined T2 and DWI, number of positive biopsy cores and Gleason score (Naiki et al., 2011) .
Metastases of hilar and mediastinal lymph nodes are detected by CT or FDG-PET, but tiny metastatic lymph nodes are difficult to be detected by CT or FDG-PET, and it is sometimes difficult for CT or FDG-PET to distinguish malignant lesions from benign lesions. DWI was reported to be able to detect more tiny metastatic lymph nodes than that detected by FDG-PET (Usuda et al., 2013) . In the paper the maximum diameter of metastatic lymph nodes were 7.2±4.1 mm in 39 detected by DWI and 11.9±4.1 mm in 24 detected by FDG-PET.
Metastasis of the liver is sometimes difficult to detect by unenhanced CT or FDG-PET. However, DWI was very useful in the detection of liver metastasis, which had distinguishable decreased diffusion different from benign lesions. It has been reported that MRI has an extremely high degree of sensitivity in the detection of colorectal liver metastasis (Blyth et al., 2008) .
Whole-body MRI with DWI can be used for bone metastasis assessment of non-small cell lung cancer patients; which is as accurate as bone scintinography and/or PET-CT (Takenaka et al., 2009 ). PET-CT appears to be slightly less sensitive than whole body MRI in the detection of osteal metastases (Ghanem et al., 2005) . Already a trial of whole-body simultaneous hybrid PET/MRI was performed for neoplastic lesions, and simultaneous PET/MRI is a promising technology for the detection of neoplastic disease (Rakheja et al., 2013) .
In the comparison between ADC of primary lung cancer and ADC of metastatic lesions, it was surprised for us that the correlation coefficient was rather low, which meant that cellular density of cancer cells would change a lot from that of the primary lung cancer because DWI represent the number and distribution of cancer cells (Usuda et al. 2013) . It may be possible to assess the pathological characteristics of metastatic lesions of primary lung cancers using DWI.
DWI was effective in detecting recurrence or metastasis of lung cancers, especially of the metastasis of hilar or mediastinal lymph nodes, liver, or bone which was rather difficult to distinguish from benign lesions by CT. DWI is useful for the detection of recurrence and metastasis of lung cancer.
